Verition Fund Management LLC Vertex Pharmaceuticals Inc Transaction History

Verition Fund Management LLC

$17.4 Billion
Q3 2024

A detailed history of Verition Fund Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 13,100 shares of VRTX stock, worth $5.38 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

13,100

Previous 8,721 50.21%

Holding current value

$5.38 Million

Previous $4.09 Million 49.06%

% of portfolio

0.04%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $2.01 Million - $2.21 Million	4,379 Added 50.21%	13,100 $6.09 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $4.64 Million - $5.73 Million	-11,804 Reduced 57.51%	8,721 $4.09 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $4.23 Million - $4.63 Million	10,380 Added 102.32%	20,525 $8.58 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $2.53 Million - $3.03 Million	7,381 Added 267.04%	10,145 $4.13 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $270,544 - $289,968	800 Added 40.73%	2,764 $961,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $9.55 Million - $10.9 Million	-33,722 Reduced 94.5%	1,964 $618,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $6.21 Million - $6.99 Million	-21,728 Reduced 37.84%	35,686 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $5.7 Million - $6.36 Million	20,821 Added 56.9%	57,414 $16.6 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $7.36 Million - $9.17 Million	31,341 Added 596.74%	36,593 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $2.21 Million - $2.78 Million	-12,458 Reduced 70.34%	5,252 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $2.47 Million - $2.76 Million	13,590 Added 329.85%	17,710 $3.21 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $353,981 - $417,436	1,888 Added 84.59%	4,120 $831,000
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $279,062 - $325,285	1,348 Added 152.49%	2,232 $479,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $55,685 - $74,268	-269 Reduced 23.33%	884 $209,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $294,764 - $349,474	1,153 New	1,153 $314,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.61 Million - $1.99 Million	-8,049 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $858,223 - $1.15 Million	5,148 Added 177.46%	8,049 $1.76 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $156,754 - $176,425	-943 Reduced 24.53%	2,901 $491,000
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $632,760 - $731,782	3,844 New	3,844 $705,000
Q3 2018 Nov 15, 2018	SELL	$167.73 - $192.74 $1.32 Million - $1.52 Million	-7,893 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $1.15 Million - $1.34 Million	7,893 New	7,893 $1.34 Million
Q4 2017 Feb 15, 2018	SELL	$137.28 - $155.55 $405,250 - $459,183	-2,952 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $437,279 - $478,932	2,952	2,952 $449,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Vertex Pharmaceuticals Inc Transaction History